Fax: (011) 86 29-84772286
Original Article
You have full text access to this OnlineOpen article
Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer†
Article first published online: 19 JUL 2011
DOI: 10.1002/cncr.26348
Copyright © 2011 American Cancer Society
Additional Information
How to Cite
Zhou, F., He, X., Liu, H., Zhu, Y., Jin, T., Chen, C., Qu, F., Li, Y., Bao, G., Chen, Z. and Xing, J. (2012), Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer, 118: 937–946. doi: 10.1002/cncr.26348
- †
The first 3 authors contributed equally to this article.
- §
Fax: (011) 86 29-84772286
Publication History
- Issue published online: 3 FEB 2012
- Article first published online: 19 JUL 2011
- Manuscript Accepted: 16 MAY 2011
- Manuscript Revised: 25 APR 2011
- Manuscript Received: 20 JAN 2011
REFERENCES
- 1, . Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet. 2004; 5: 407-441.
- 2, , . The role of mammalian circadian proteins in normal physiology and genotoxic stress responses. Curr Top Dev Biol. 2007; 78: 173-216.
- 3, , , et al. Interacting molecular loops in the mammalian circadian clock. Science. 2000; 288: 1013-1019.
- 4, , , , . Posttranslational mechanisms regulate the mammalian circadian clock. Cell. 2001; 107: 855-867.
- 5, , , , , . BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev. 2003; 17: 1921-1932.
- 6, , . CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat Neurosci. 2007; 10: 543-545.
- 7, . A CLOCK-less clock. Trends Cell Biol. 2006; 16: 547-549.
- 8, , , et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999; 98: 193-205.
- 9. Molecular bases for circadian clocks. Cell. 1999; 96: 271-290.
- 10, , , et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005; 308: 1043-1045.
- 11, , , et al. Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci U S A. 2007; 104: 14412-14417.
- 12, , . Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond). 2008; 32: 658-662.
- 13, , , , , . Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr. 2008; 87: 1606-1615.
- 14, , , et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8: 1065-1066.
- 15, . British Airways flightdeck mortality study, 1950-1992. Aviat Space Environ Med. 1999; 70: 548-555.
- 16, , , et al. Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med. 2003; 74: 699-706.
- 17, , , et al. Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer. 2007; 120: 432-435.
- 18, , , et al. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat. 2008; 107: 421-425.
- 19, , , et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009; 69: 8447-8454.
- 20, , , et al. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Res Treat. 2010; 120: 663-669.
- 21, , , et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog. 2008; 47: 925-933.
- 22
- 23, , , . Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59: 366-378.
- 24, , , . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.Direct Link:
- 25, , , et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124: 979-994.
- 26, , , , . Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009; 27: 5938-5943.
- 27. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003; 19: 660-666.
- 28, , , et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009; 301: 393-403.
- 29, , , et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461: 399-401.
- 30, , , et al. Genetic differences in human circadian clock genes among worldwide populations. J Biol Rhythms. 2008; 23: 330-340.
- 31, . SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009; 37: W600-W605.
- 32, , , et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 2009; 69: 9315-9322.
- 33, , , et al. High-resolution time course analysis of gene expression from pituitary. Cold Spring Harb Symp Quant Biol. 2007; 72: 381-386.
- 34, , , , , . Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003; 302: 255-259.
- 35, , , , . The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002; 111: 41-50.
- 36, , , et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002; 9: 1031-1044.
- 37, , , , . The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem. 2008; 283: 4535-4542.
- 38, , , . c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur J Cancer. 1994; 30A: 1113-1117.
- 39, , , et al. p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2513-2521.
- 40, , . Circadian regulator CLOCK is a histone acetyltransferase. Cell. 2006; 125: 497-508.
- 41, . Cyclin D1 and breast cancer. Breast. 2006; 15: 718-727.
- 42, , , et al. CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int J Obes (Lond). 2010; 34: 516-523.
- 43, , , . T3111C clock single nucleotide polymorphism and mood disorders: a meta-analysis. Chronobiol Int. 2010; 27: 706-721.
- 44, , , et al. Genetic variants in human CLOCK associate with total energy intake and cytokine sleep factors in overweight subjects (GOLDN population). Eur J Hum Genet. 2010; 18: 364-369.
- 45, , , et al. CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 2010; 70: 1459-1468.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
